Administration of Lapatinib with Food Increases Its Plasma Concentration in Chinese Patients with Metastatic Breast Cancer: A Prospective Phase II Study

LESSONS LEARNED: Administration of lapatinib with food significantly increased its plasma concentration in Chinese patients with metastatic breast cancer. There were no serious adverse events during the study and no significant differences in lapatinib‐related adverse events between the fasted and f...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncologist
Päätekijät: Xu, Fei, Lee, Kaping, Xia, Wen, Liao, Hai, Lu, Qianyi, Zhang, Jingmin, Yuan, Huimin, Zhang, Kai, Zheng, Qiufan, Qin, Ge, Zhai, Qinglian, Hong, Ruoxi, Jiang, Kuikui, Li, Yuan, Wang, Shusen
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley & Sons, Inc. 2020
Aiheet:
Clinical Trial Results
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7485350/
https://ncbi.nlm.nih.gov/pubmed/32058619
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2020-0044
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia